MariMed Inc. (MRMD) stock
Close on Oct 19, 2026Market cap $22.78MP/E –Yield –
MariMed Inc. grew revenue 4.4% to $163.82M over the twelve months to Jun 30, 2026. Free cash flow was $8.01M. At the latest close the market valued the company at $22.78M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $22.78M
- P/E ratio
- –
- Price to sales
- 0.14
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 35.17%
Fundamentals
- Revenue
- $163.82M
- Net income
- -$14.95M
- EPS, diluted
- -$0.04
- Free cash flow
- $8.01M
- Diluted shares
- 400M
Trading
- Next earnings
- Nov 4, 2026 (estimated, after the close)
- Previous close
- $0.06
- Open
- $0.06
- Day's range
- $0.06 – $0.06
- Volume
- 208,369
- Average volume (20 days)
- 666,801
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | MRMD | S&P 500 | Difference | MRMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -22.0% | +0.6% | −22.7 pts | ||
| 3 months | -13.4% | +3.4% | −16.7 pts | ||
| Year to date | -39.3% | +13.3% | −52.6 pts | ||
| 1 year | -62.7% | +16.6% | −79.3 pts | ||
| 3 years | -85.4% | +86.4% | −171.8 pts | -47.3% | +23.1% |
| 5 years | -93.0% | +81.9% | −174.9 pts | -41.3% | +12.7% |
| 10 years | -54.4% | +318.9% | −373.3 pts | -7.6% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases MariMed filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Results
- Results
- Results
- Results
About MariMed
Medicinal Chemicals & Botanical Products
MariMed Inc. is a multi-state cannabis operator engaged in the cultivation, production, and dispensing of medicinal and adult-use cannabis products. The company develops and markets proprietary brands across various consumption formats, including flower, concentrates, vape cartridges, edibles, and drink mixes. Its core operational segments comprise wholesale distribution and retail dispensary sales. In wholesale, MariMed sells manufactured branded items to licensed third-party dispensaries. In retail, it serves medical patients and recreational consumers seeking wellness, relaxation, and relief through physical dispensaries as well as home delivery services in select jurisdictions.
Company profile, executives and historyMariMed stock: common questions
What is MariMed's stock price?
MRMD closed at $0.06 on Oct 19, 2026, down 3.39% on the day.
What is MariMed's market cap?
MariMed was worth $22.78M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is MRMD's P/E ratio?
MariMed lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.04), so it has no meaningful P/E ratio.
How much revenue does MariMed make?
MariMed reported revenue of $163.82M for the twelve months to Jun 30, 2026, up 4.4% from a year earlier.
Does MariMed pay a dividend?
No. MariMed has not paid a cash dividend over the last twelve months.
When does MariMed report earnings next?
MariMed is expected to report Q3 FY2026 results on Nov 4, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has MRMD stock performed over the past year?
Including dividends, MRMD returned -62.7% over the past year, against +16.6% for the S&P 500.
Who are MariMed's competitors?
Companies most similar to MariMed by business, industry and size include JUSH, AAWH, GLAS, CRON, CRLBF.
See a number that looks wrong?